GO:1900745 positive regulation of p38MAPK cascade: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900745 describes any process that activates or increases the frequency, rate or extent of the p38MAPK cascade.
• The p38MAPK cascade is a stress-activated signaling module that controls inflammation, differentiation, and cell survival.
• Positive regulation of p38MAPK cascade is mediated by upstream kinases such as MAP3K3 and by scaffold proteins that assemble the kinase module.
• Dysregulated p38MAPK activation contributes to cancer progression, chemoresistance, and fibrotic remodeling.
• Optogenetic and pharmacological tools allow precise dissection of p38MAPK cascade activation in live cells.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to establish causality for genes that regulate p38MAPK signaling.
Description
The Gene Ontology term GO:1900745, positive regulation of p38MAPK cascade, defines any process that activates or increases the frequency, rate or extent of the p38MAPK cascade. The p38MAPK cascade is a conserved signaling pathway that responds to environmental stress, inflammatory cytokines, and growth factors, and it ultimately controls the activity of p38 mitogen-activated protein kinases (MAPKs). Because p38MAPK signaling influences cell proliferation, differentiation, apoptosis, and migration, understanding how this cascade is positively regulated is central to both basic cell biology and translational research.
positive regulation of p38MAPK cascade At A Glance
| GO ID | GO:1900745 |
|---|---|
| GO term | positive regulation of p38MAPK cascade |
| Ontology | biological_process |
| Synonym | activation of p38 cascade; upregulation of p38 MAPK cascade; positive regulation of osmosensory signaling MAPK cascade |
| Major function | Increases the activity of the p38MAPK signaling cascade in response to stress, cytokines, or other stimuli |
| Related kinases | MAP3K3, MAP2K3/6, p38MAPK isoforms |
| Cellular context | Cytoplasm, nucleus, and scaffold-associated signaling complexes |
| Disease relevance | Cancer, fibrosis, inflammation, and chemoresistance |
What Is GO:1900745?
In my own words, GO:1900745 refers to any biological process that turns on or enhances the p38MAPK signaling cascade. This includes events such as activation of upstream MAP3Ks and MAP2Ks, scaffold-mediated assembly of the kinase module, and post-translational modifications that increase p38MAPK phosphorylation and downstream substrate engagement. The term is not restricted to a single molecular mechanism; rather, it captures the net positive effect on the cascade's activity.
Why Is positive regulation of p38MAPK cascade Important in Cell Biology?
Positive regulation of the p38MAPK cascade is important because it determines the magnitude and duration of stress-activated signaling that shapes cell fate decisions. Aberrant activation of this cascade is linked to tumor progression, resistance to therapy, and tissue fibrosis, making it a target for mechanistic studies and drug discovery.
• Controls inflammatory cytokine production and immune cell activation.
• Regulates cell cycle checkpoints and DNA damage responses through MK2.
• Promotes differentiation of odontoblasts and other specialized cell types.
• Contributes to letrozole resistance in breast cancer cells.
• Drives fibrotic gene programs in liver and other tissues.
• Modulates testosterone decline in response to environmental toxicants.
• Provides a node for crosstalk with ERK signaling.
• Serves as a therapeutic target in colorectal cancer and other malignancies.
• Enables optogenetic control of kinase activity for precise perturbation.
• Offers a paradigm for studying scaffold-dependent kinase activation.
What Happens During positive regulation of p38MAPK cascade?
Upstream kinase activation
In simple terms: First, kinases upstream of p38 get turned on.
Positive regulation often begins with activation of MAP3Ks such as MAP3K3, which phosphorylate and activate MAP2Ks (MKK3/6). USP13 stabilizes MAP3K3 to promote colorectal cancer progression, illustrating how upstream kinase abundance can drive cascade activation. Similarly, NBL1 blocks PDGF-BB-induced p38MAPK activation in pulmonary artery smooth muscle cells, showing that extracellular cues can either stimulate or inhibit this step.
Scaffold assembly and signalosome formation
In simple terms: Scaffold proteins bring the kinases together so they can pass the signal along.
Scaffold proteins organize MAP3K, MAP2K, and p38MAPK into signaling complexes that enhance cascade efficiency. In odontoblast differentiation, epigenetic modulation influences the expression of genes that may serve as scaffolds or adaptors for p38MAPK activation. The precise composition of these signalosomes determines the specificity and duration of the positive regulation.
p38MAPK phosphorylation and substrate engagement
In simple terms: The p38 kinase gets phosphorylated and then acts on its targets.
Once MAP2Ks phosphorylate p38MAPK on Thr-Gly-Tyr motifs, the active kinase phosphorylates downstream substrates such as MK2, transcription factors, and other effectors. This step is the hallmark of cascade activation and is often measured as an increase in phospho-p38 levels. Optogenetic activation of p38 revealed crosstalk with ERK signaling, indicating that positive regulation can have system-level consequences.
Feedback and crosstalk regulation
In simple terms: The cascade can be tuned by feedback loops and other pathways.
Positive regulation of p38MAPK cascade is balanced by phosphatases, feedback phosphorylation, and crosstalk with other MAPK modules. For example, p38-ERK crosstalk was observed upon isoform-specific optical activation, demonstrating that increasing p38 activity can modulate ERK signaling. In liver fibrosis, genome-wide DNA methylation changes may alter expression of regulators that sustain p38MAPK activation.
Key Genes Involved in GO:1900745 positive regulation of p38MAPK cascade
The following genes and proteins are experimentally implicated in the positive regulation of the p38MAPK cascade, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAP3K3 | Upstream MAP3K that activates MKK3/6 | Stabilized by USP13 in colorectal cancer; target for KO and point-mutation studies |
| MAP2K3 | MAP2K that phosphorylates p38MAPK | Key node for cascade activation; suitable for knock-in of phospho-mimetic mutants |
| MAP2K6 | MAP2K that phosphorylates p38MAPK | Alternative MAP2K; can be knocked out to dissect isoform-specific effects |
| p38MAPK (MAPK14) | Terminal kinase of the cascade | Central effector; overexpression and point-mutation models are widely used |
| MK2 (MAPKAPK2) | Downstream substrate of p38MAPK | Mediates cell cycle checkpoint control; KO models reveal p38-dependent phenotypes |
| NBL1 | Inhibitor of PDGF-BB-induced p38MAPK activation | Modulates PASMC proliferation; useful for overexpression studies |
| PDGF-BB | Growth factor that activates p38MAPK | Stimulus for positive regulation in vascular cells |
| USP13 | Deubiquitinase that stabilizes MAP3K3 | Promotes colorectal cancer progression; KO reduces p38MAPK activation |
| miR-140-5p | Intronic miRNA affecting p38MAPK signaling | Linked to beta-cypermethrin-mediated testosterone decline; KO and overexpression models |
| Chk1 | DNA damage checkpoint kinase | Can influence p38MAPK pathway via MK2; KO sensitizes cells to stress |
| Chk2 | DNA damage checkpoint kinase | Interacts with p38MAPK signaling in stress responses |
| p38 isoforms (MAPK11/12/13/14) | Terminal kinases with distinct functions | Isoform-specific optical activation reveals crosstalk |
| Scaffold proteins (e.g., JIP, KSR) | Assemble MAPK modules | Modulate efficiency of positive regulation; candidates for knock-in tagging |
| Transcription factors (e.g., ATF2, MEF2) | Downstream effectors of p38MAPK | Reporters for cascade activation; point mutations alter binding |
| Phosphatases (e.g., DUSP1, PP2C) | Negative regulators of p38MAPK | KO increases cascade activity; balance positive regulation |
| Epigenetic modifiers (e.g., DNMTs) | Regulate expression of cascade components | DNA methylation dynamics affect p38MAPK regulators in fibrosis |
| Letrozole resistance mediators | Adaptive signaling through p38MAPK | Overexpression models mimic resistance; KO reverses phenotype |
How Is positive regulation of p38MAPK cascade Regulated?
Positive regulation of the p38MAPK cascade is itself regulated at multiple levels. Upstream kinases such as MAP3K3 are controlled by ubiquitination and deubiquitination; USP13 stabilizes MAP3K3 to sustain cascade activation in colorectal cancer. Extracellular signals, including PDGF-BB, can either stimulate or be blocked by inhibitors like NBL1. Intronic microRNAs such as miR-140-5p modulate p38MAPK signaling in endocrine tissues. Epigenetic mechanisms, including DNA methylation, alter the expression of cascade regulators during liver fibrosis. Finally, crosstalk with ERK signaling provides a layer of network-level control.
positive regulation of p38MAPK cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USP13 | Colorectal cancer progression | Knockout of USP13 in HCT116 cells; measure p38MAPK activation |
| MAP3K3 | Colorectal cancer | Point mutation of ubiquitination sites; knock-in of stabilized mutant |
| p38MAPK (MAPK14) | Letrozole-resistant breast cancer | Overexpression of constitutively active p38 in MCF-7 cells |
| NBL1 | Pulmonary arterial hypertension | Overexpression of NBL1 in PASMCs; assess p38MAPK phosphorylation |
| miR-140-5p | Testosterone decline | Knockout of intronic miR-140-5p in Leydig cells |
Cancer progression and chemoresistance
Positive regulation of the p38MAPK cascade is hijacked in multiple cancers. USP13 promotes colorectal cancer progression by stabilizing MAP3K3, thereby enhancing p38MAPK signaling. In breast cancer, acquisition of letrozole resistance is associated with activation of the p38/MAPK signaling cascade, suggesting that positive regulators of this pathway contribute to endocrine therapy failure.
Fibrosis and tissue remodeling
In carbon tetrachloride-induced liver fibrosis, genome-wide DNA methylation dynamics alter the expression of genes that regulate p38MAPK signaling, linking epigenetic reprogramming to sustained cascade activation. Similarly, in pulmonary artery smooth muscle cells, NBL1 inhibits PDGF-BB-induced p38MAPK activation, indicating that loss of negative control can promote vascular remodeling.
Reproductive and developmental toxicity
Beta-cypermethrin exposure leads to testosterone decline through an intronic miR-140-5p mechanism that involves p38MAPK signaling, highlighting the role of positive regulation in endocrine disruption. In odontoblast differentiation, epigenetic modulation of p38MAPK-related genes influences regenerative endodontics outcomes.
From positive regulation of p38MAPK cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of USP13 reduce p38MAPK cascade activation? | CRISPR knockout of USP13 in colorectal cancer cell lines |
| Does a phospho-mimetic MAP2K3 mutant enhance p38MAPK signaling? | Point mutation (e.g., S/T to D) knock-in in HEK293T cells |
| Can a tagged p38MAPK reporter track cascade dynamics? | Knock-in of fluorescent protein tag at the MAPK14 locus |
| Does overexpression of NBL1 block PDGF-BB-induced p38MAPK activation? | Overexpression of NBL1 in pulmonary artery smooth muscle cells |
| Does miR-140-5p deletion alter testosterone production? | Knockout of miR-140-5p in mouse Leydig cell line |
| Does epigenetic editing of a p38MAPK regulator affect odontoblast differentiation? | CRISPR-dCas9-DNMT3A knock-in for targeted methylation |
How to Study the positive regulation of p38MAPK cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Phospho-p38MAPK and total p38MAPK levels | Validation of cascade activation after gene knockout |
| Phospho-proteomics | Global phosphorylation changes | Mapping downstream effectors of positive regulation |
| Optogenetic activation | Kinase activity with spatial and temporal control | Studying p38-ERK crosstalk |
| RNA-seq | Transcriptional changes | Identifying gene expression programs driven by p38MAPK |
| DNA methylation profiling | Epigenetic modifications | Linking epigenetic changes to p38MAPK regulators in fibrosis |
| CRISPR knockout screening | Gene essentiality for cascade activation | Discovery of novel positive regulators |
| Live-cell imaging | Dynamic kinase activity | Tracking p38MAPK activation in real time |
| Co-immunoprecipitation | Protein-protein interactions | Detecting scaffold-kinase complexes |
Phospho-proteomics and Western blotting
Measuring phospho-p38MAPK levels by Western blot is the standard readout for cascade activation. Phospho-proteomics can quantify changes across the MAPK network after genetic perturbation, as shown in studies of USP13 and MAP3K3.
Optogenetic and live-cell imaging
Isoform-specific optical activation of kinase function enables precise spatiotemporal control of p38MAPK activity and reveals crosstalk with ERK signaling in live cells. Fluorescent reporters knocked into the MAPK14 locus allow real-time monitoring of cascade dynamics.
Transcriptomics and epigenomics
RNA-seq and genome-wide DNA methylation profiling identify genes and pathways that co-vary with p38MAPK activation. In liver fibrosis, DNA methylation dynamics revealed epigenetic regulation of p38MAPK-related genes. In odontoblast differentiation, epigenetic modulation of p38MAPK signaling was studied using similar approaches.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens can identify positive regulators of the p38MAPK cascade. For example, targeting deubiquitinases like USP13 uncovered its role in stabilizing MAP3K3 and promoting colorectal cancer progression. Such screens are powerful for discovering novel regulators of GO:1900745.
How CRISPR Can Be Used to Study GO:1900745 positive regulation of p38MAPK cascade
Knockout
CRISPR knockout of genes such as USP13 or MAP3K3 can abolish or reduce positive regulation of the p38MAPK cascade, providing causal evidence for their role. For example, knockout of USP13 in colorectal cancer cells destabilizes MAP3K3 and decreases p38MAPK activation.
Point Mutation
Point mutations can be introduced to mimic or block phosphorylation. For instance, mutating the ubiquitination sites on MAP3K3 can stabilize the protein and enhance cascade activation, while phospho-deficient mutants of p38MAPK can prevent downstream signaling.
Knock-in
Knock-in of fluorescent tags or epitope tags at endogenous loci allows tracking of p38MAPK cascade components. Tagged MAPK14 knock-in cells enable live-cell imaging of kinase dynamics and localization. Knock-in of methylation editors can also be used to study epigenetic regulation of cascade genes.
Overexpression
Overexpression of positive regulators such as constitutively active MAP2K3 or p38MAPK isoforms can amplify the cascade. Conversely, overexpression of inhibitors like NBL1 can block PDGF-BB-induced p38MAPK activation, demonstrating the utility of gain-of-function models.
How EDITGENE Supports positive regulation of p38MAPK cascade Research
Researchers studying positive regulation of p38MAPK cascade-related genes often need to determine whether a candidate gene is causally involved in activating or enhancing the cascade. EDITGENE provides a comprehensive suite of CRISPR services to enable such mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of p38MAPK cascade research.
Frequently Asked Questions About positive regulation of p38MAPK cascade
What is GO:1900745?
GO:1900745 is the Gene Ontology term for positive regulation of p38MAPK cascade, defined as any process that activates or increases the frequency, rate or extent of the p38MAPK cascade.
What genes are involved in positive regulation of p38MAPK cascade?
Key genes include MAP3K3, MAP2K3, MAP2K6, p38MAPK (MAPK14), USP13, NBL1, and MK2, among others.
How is p38MAPK cascade activated?
Activation typically involves upstream MAP3Ks phosphorylating MAP2Ks, which then phosphorylate p38MAPK on Thr-Gly-Tyr motifs, leading to downstream substrate engagement.
What diseases are associated with p38MAPK cascade activation?
Dysregulated p38MAPK activation is linked to colorectal cancer, letrozole-resistant breast cancer, liver fibrosis, and reproductive toxicity.
What research methods are used to study positive regulation of p38MAPK cascade?
Common methods include Western blotting for phospho-p38, phospho-proteomics, optogenetic activation, RNA-seq, and CRISPR screens.
How can CRISPR be used to study p38MAPK cascade regulators?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in the cascade.
What is the role of USP13 in p38MAPK signaling?
USP13 stabilizes MAP3K3, thereby promoting p38MAPK cascade activation and colorectal cancer progression.
How does NBL1 affect p38MAPK activation?
NBL1 inhibits PDGF-BB-induced p38MAPK activation in pulmonary artery smooth muscle cells, blocking proliferation.
Is p38MAPK involved in letrozole resistance?
Yes, acquisition of letrozole resistance is associated with activation of the p38/MAPK signaling cascade in breast cancer models.
What is the connection between p38MAPK and DNA damage?
p38MAPK and its downstream kinase MK2 are involved in cell cycle checkpoint control in response to DNA damage, alongside Chk1 and Chk2.
Conclusion
GO:1900745, positive regulation of p38MAPK cascade, is a critical biological process that governs cellular responses to stress and cytokines. Its dysregulation contributes to cancer, fibrosis, and other diseases, making it a rich area for mechanistic and translational research. By leveraging CRISPR-based models and multi-omics methods, researchers can dissect the precise regulators of this cascade and identify new therapeutic targets.
References
- 1. Zhang Q et al.. 2025. Epigenetic modulation of odontoblast differentiation: implications for regenerative endodontics.. J Dent 161:105978 PMID: 40669605
- 2. Chang SY et al.. 2025. Ubiquitin-specific protease 13 promotes colorectal cancer progression by stabilizing mitogen-activated protein kinase kinase 3.. Mol Biomed 6(1):122 PMID: 41307804
- 3. Cui C et al.. 2016. Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.. Biosci Rep 36(4) PMID: 27474499
- 4. Walker RR et al.. 2021. Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade.. Anticancer Res 41(2):583-599 PMID: 33517263
- 5. Duan P et al.. 2022. Intronic miR-140-5p contributes to beta-cypermethrin-mediated testosterone decline.. Sci Total Environ 806(Pt 1):150517 PMID: 34794910
- 6. Li D et al.. 2023. Genome-wide DNA methylation dynamics in carbon tetrachloride-induced mice liver fibrosis.. Iran J Basic Med Sci 26(1):85-92 PMID: 36594057
- 7. Zhou W et al.. 2023. Isoform-specific optical activation of kinase function reveals p38-ERK signaling crosstalk.. RSC Chem Biol 4(10):765-773 PMID: 37799579
- 8. Reinhardt HC et al.. 2009. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.. Curr Opin Cell Biol 21(2):245-55 PMID: 19230643
